Peripheral vascular disease (PVD)—a condition affecting arteries, veins and the lymphatic systems throughout the body—has significant differences in incidence, risk factors, diagnosis, treatment and ...

The Food and Drug Administration (FDA) has approved TNKase ® (tenecteplase) for the treatment of acute ischemic stroke (AIS) in adults.

The following is a summary of “Reducing time delays and enhancing reperfusion eligibility related to stroke suspicion by the ...

The ambulance would be the latest addition to Florida’s first mobile stroke treatment unit network, which speeds care to ...

(HealthDay News) — The US Food and Drug Administration has approved TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.

Stroke is the fifth-leading cause of death nationwide. Brain damage from strokes can be minimized if they are treated ...

A Gering teenager is on the road to recovery after a life-threatening ATV accident and subsequent stroke, thanks to the swift ...

Every year, millions of people die from stroke. In order to win against this disease which occurs the moment when a blood ...

Genentech, a member of the Roche Group, today announced that the U.S. Food and Drug Administration (FDA) has approved TNKase® (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment ...

CNN wellness expert Dr. Leana Wen recommends five things to do to stay healthy and avoid having to rely on the emergency room ...

There’s a 40% higher likelihood that they will survive compared to standard EMS,” said David Lykens, ACFR Captain of EMS ...